Clinical Trial: A Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06848348) titled 'A Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain' on Feb. 03.

Brief Summary: A randomized study to determine safety and efficacy of single subcutaneous (SC) administration of HAL treatment in patients with CINP.

Study Start Date: Feb., 2025

Study Type: INTERVENTIONAL

Condition: Chemotherapy Induced Neuropathic Pain

Intervention: DRUG: Halneuron

Halneuron for Subcutaneous Injection

DRUG: Placebo

Placebo for Subcutaneous Injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Dogwood Therapeutics Inc.

Published by...